20 Sept 2017 Jahr - FDA advised that the opioid addiction
medications buprenorphine and methadone
should not be withheld from patients taking
benzodiazepines or other drugs that depress the
central nervous system (CNS). The combined use
of these drugs increases the risk of serious side
effects; however, the harm caused by untreated
opioid addiction can outweigh these risks. Careful
medication management by health care
professionals can reduce these risks.
Zugefügt zum Band der Zeit:
Opioids and the FDA
Datum:
